市場調查報告書

全球手術中放射線治療市場:成長,趨勢,及預測

Intraoperative Radiation Therapy Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921990
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
全球手術中放射線治療市場:成長,趨勢,及預測 Intraoperative Radiation Therapy Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

本報告提供全球手術中放射線治療(IORT)市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,方法·產品&服務·用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 全球癌症的增加率
    • 癌症治療技術的進步
    • IORT對外部束放射療法的優點
  • 市場阻礙因素
    • 技術複雜且缺乏訓練有素的人員
    • 術前放療前的常規放療
  • 波特的五力分析

第5章 市場區隔

  • 各方法
    • 電子IORT
    • 手術中近距離放射療法
  • 各產品及服務
    • 產品
    • 服務
  • 各用途
    • 乳癌
    • 腦瘤
    • 消化道惡性腫瘤
    • 頭頸椎癌症
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Ariane Medical Systems, Ltd.
    • Eckert & Ziegler
    • Elekta AB
    • GMV Innovating Solutions
    • ICAD, Inc.
    • Intraop Medical Corporation
    • Sensus Healthcare, Inc.
    • Sordina IORT Technologies
    • Varian Medical Systems, Inc.
    • Zeiss Group

第7章 市場機會及今後趨勢

目錄
Product Code: 67633

Market Overview

Intraoperative radiation therapy (IORT) is an intensive radiation treatment that's administered during surgery. IORT allows direct radiation to the target area while sparing normal surrounding tissue. IORT is used to treat cancers that are difficult to remove during surgery and when there is a concern that microscopic amounts of cancer may remain.

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

However, the lack of skilled personnel to operate the equipment and preference for conventional radiotherapy over IORT are hindering the growth of the market.

Scope of the Report

Intraoperative radiation therapy (IORT) is an intensive radiation treatment that's administered during surgery. IORT allows direct radiation to the target area while sparing normal surrounding tissue. IORT is used to treat cancers that are difficult to remove during surgery and when there is a concern that microscopic amounts of cancer may remain.

In the report, a detailed analysis of the intraoperative radiation therapy market is provided. The market is evaluated by collating revenues generated across segments, categorized by Method, Product & Service, Application and Geography.

Key Market Trends

Electron IORT is Expected to Cover a Large Share of the Market

Electron Intraoperative radiation therapy or Intraoperative electron radiation therapy (IOERT) is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment because, depending on the electron energy, the dose falls off rapidly behind the target site, therefore sparing underlying healthy tissue. One advantage of IOERT is that it can be given at the time of surgery when microscopic residual tumor cells are most vulnerable to destruction. IOERT is also often used in combination with external beam radiotherapy (EBRT) because it results in less integral doses and shorter treatment times.

Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 (17 million).

Hence, with the increasing prevalence of cancer globally, the demand for novel therapies like IOERT, with advantages over conventional methods is expected to increase, if the awareness regarding these techniques increases.

North America is Expected to Dominate the Market

The prevalence of cancer in the United States (US) is one of the highest in the world. As per a 2018 report by the World Cancer Research Fund International, the prevalence of cancer in the US is 352.2 per 100,000. As per the same report, Canada also has a high prevalence of cancer with 334 per 100,000 Canadians suffering from the dreadful disease. This high prevalence of cancer has increased the economic burden of cancer of the population of this region.

However, the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada.

As a result, these countries enjoy the presence of many global market players. Hence, as high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

The majority of the intraoperative radiation therapy instruments are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Global Prevalence of Cancer
    • 4.2.2 Advancements in Cancer Therapy Technologies
    • 4.2.3 Advantages of IORT over External beam radiotherapy
  • 4.3 Market Restraints
    • 4.3.1 Complexity of Technology and Shortage of Trained Personnel
    • 4.3.2 Preference for Conventional Radiotherapy Over Intraoperative Radiation Therapy
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Method
    • 5.1.1 Electron IORT
    • 5.1.2 Intraoperative Brachytherapy
  • 5.2 By Product & Service
    • 5.2.1 Products
      • 5.2.1.1 Systems/Accelerators
      • 5.2.1.2 Applicators & Afterloaders
      • 5.2.1.3 Treatment Planning Systems
      • 5.2.1.4 Accessories
    • 5.2.2 Services
  • 5.3 By Application
    • 5.3.1 Breast Cancer
    • 5.3.2 Brain Tumor
    • 5.3.3 Gastrointestinal Cancer
    • 5.3.4 Head & Neck Cancer
    • 5.3.5 Other Cancers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ariane Medical Systems, Ltd.
    • 6.1.2 Eckert & Ziegler
    • 6.1.3 Elekta AB
    • 6.1.4 GMV Innovating Solutions
    • 6.1.5 ICAD, Inc.
    • 6.1.6 Intraop Medical Corporation
    • 6.1.7 Sensus Healthcare, Inc.
    • 6.1.8 Sordina IORT Technologies
    • 6.1.9 Varian Medical Systems, Inc.
    • 6.1.10 Zeiss Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS